216 related articles for article (PubMed ID: 33173975)
1. Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient‑derived organoids.
Park M; Kwon J; Shin HJ; Moon SM; Kim SB; Shin US; Han YH; Kim Y
Int J Oncol; 2020 Dec; 57(6):1307-1318. PubMed ID: 33173975
[TBL] [Abstract][Full Text] [Related]
2. Effect of butyrate enemas on gene expression profiles and endoscopic/histopathological scores of diverted colorectal mucosa: A randomized trial.
Luceri C; Femia AP; Fazi M; Di Martino C; Zolfanelli F; Dolara P; Tonelli F
Dig Liver Dis; 2016 Jan; 48(1):27-33. PubMed ID: 26607831
[TBL] [Abstract][Full Text] [Related]
3. Effect of short-chain fatty acids on the human colonic mucosa in vitro.
Scheppach W; Bartram P; Richter A; Richter F; Liepold H; Dusel G; Hofstetter G; Rüthlein J; Kasper H
JPEN J Parenter Enteral Nutr; 1992; 16(1):43-8. PubMed ID: 1738218
[TBL] [Abstract][Full Text] [Related]
4. [Application of endoscopic tattooing with carbon nanoparticlet in the treatment for advanced colorectal cancer].
Wang R; Zhan HL; Li DZ; Li HT; Yu L; Wang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):56-64. PubMed ID: 31958932
[No Abstract] [Full Text] [Related]
5. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
[TBL] [Abstract][Full Text] [Related]
6. Survival Outcomes After Surgical Management of the Primary Tumor With and Without Radiotherapy for Metastatic Rectal Adenocarcinoma: A National Cancer Database (NCDB) Analysis.
Renz P; Wegner RE; Hasan S; Brookover R; Finley G; Monga D; Raj M; McCormick J; Kirichenko A
Clin Colorectal Cancer; 2019 Jun; 18(2):e237-e243. PubMed ID: 30905549
[TBL] [Abstract][Full Text] [Related]
7. Re-irradiation for recurrent rectal cancer - a single-center experience.
Al-Haidari G; Skovlund E; Undseth C; Rekstad BL; Larsen SG; Åsli LM; Dueland S; Malinen E; Guren MG
Acta Oncol; 2020 May; 59(5):534-540. PubMed ID: 32056476
[No Abstract] [Full Text] [Related]
8. The effects of therapeutic radiation on colonic mucosa.
Weisbrot IM; Liber AF; Gordon BS
Cancer; 1975 Sep; 36(3):931-40. PubMed ID: 1182679
[TBL] [Abstract][Full Text] [Related]
9. Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer.
D'Argenio G; Mazzacca G
Adv Exp Med Biol; 1999; 472():149-58. PubMed ID: 10736623
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic landscape of sodium butyrate-induced growth inhibition of human colorectal cancer organoids.
Li F; Wu Y; Yan Y; Wu S; Zhu J; Zhang G; Zhang P; Yuan L; Zeng Y; Liu Z
Mol Omics; 2022 Sep; 18(8):754-764. PubMed ID: 35837877
[TBL] [Abstract][Full Text] [Related]
11. NCoR1 Protects Mice From Dextran Sodium Sulfate-Induced Colitis by Guarding Colonic Crypt Cells From Luminal Insult.
Mennillo E; Yang X; Paszek M; Auwerx J; Benner C; Chen S
Cell Mol Gastroenterol Hepatol; 2020; 10(1):133-147. PubMed ID: 32044398
[TBL] [Abstract][Full Text] [Related]
12. NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial).
Brouquet A; Bachet JB; Huguet F; Karoui M; Artru P; Sabbagh C; Lefèvre JH; Vernerey D; Mariette C; Vicaut E; Benoist S;
BMC Cancer; 2020 May; 20(1):485. PubMed ID: 32471382
[TBL] [Abstract][Full Text] [Related]
13. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
14. Flagellin or lipopolysaccharide treatment modified macrophage populations after colorectal radiation of rats.
Lacavé-Lapalun JV; Benderitter M; Linard C
J Pharmacol Exp Ther; 2013 Jul; 346(1):75-85. PubMed ID: 23596059
[TBL] [Abstract][Full Text] [Related]
15. An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A).
Fu Q; Du Y; Yang C; Zhang D; Zhang N; Liu X; Cho WC; Yang Y
Expert Opin Ther Targets; 2016 Jul; 20(7):771-82. PubMed ID: 27167185
[TBL] [Abstract][Full Text] [Related]
16. Butyrate-induced transcriptional changes in human colonic mucosa.
Vanhoutvin SA; Troost FJ; Hamer HM; Lindsey PJ; Koek GH; Jonkers DM; Kodde A; Venema K; Brummer RJ
PLoS One; 2009 Aug; 4(8):e6759. PubMed ID: 19707587
[TBL] [Abstract][Full Text] [Related]
17. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
18. Does ursodeoxycholic acid change the proliferation of the colorectal mucosa?. A randomized, placebo-controlled study.
Ochsenkühn T; Marsteller I; Hay U; Diebold J; Paumgartner G; Göke B; Sackmann M
Digestion; 2003; 68(4):209-16. PubMed ID: 14707397
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of the anti-proliferative effects of butyrate and aspirin on human colonic mucosa in vitro.
Gostner A; Dusel G; Kelber E; Scheppach W; Bartram HP
Eur J Cancer Prev; 2000 Jun; 9(3):205-11. PubMed ID: 10954260
[TBL] [Abstract][Full Text] [Related]
20. Pathological Predictors of Response to Neoadjuvant Treatment in Rectal Carcinoma.
Malekzadeh Moghani M; Alahyari S; Moradi A; Nasiri M
J Gastrointest Cancer; 2021 Jun; 52(2):690-695. PubMed ID: 32643115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
